In the News
X
Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents
Business Wire - October 13, 2022
TwinStrand Biosciences Announces Leadership Transition
Globe Newswire - June 06, 2022
Singular Genomics and TwinStrand Biosciences Collaborate to Develop Ultra-high Accuracy NGS Solutions for the G4 Platform
Life Science Washington - April 20, 2022
Life Science Innovation Northwest 2022
Our CEO, Jesse Salk MD, PhD will be speaking at the Life Sciences Innovation Northwest (LSINW) 2022 Convention during the Research Tools & Medical Device session.
Wednesday, April 20th, 2022 – 2:46pm PST
Inside Precision News - April 12, 2022
How Duplex Sequencing Can Improve MRD Detection: An Interview with Jesse Salk, MD, PhD, CEO of TwinStrand Biosciences
TwinStrand Biosciences - February 24, 2022
National Firefighter Cancer Symposium 2022
This year we were proud to sponsor the scientific workshop Applying Molecular Biology & Genetic Toxicology Methods to Improve Risk Assessment and Guide Risk Management Decisions for Cancer in Firefighters at the 2022 National Cancer Fire Symposium, hosted by the Firefighter Cancer Initiative (FCI).
FNIH - February 11, 2022
TwinStrand partners with the FNIH in Project for Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
TwinStrand Biosciences, Inc. was selected to join the FNIH Biomarkers Consortium Project aiming to establish new methods for detecting measurable residual disease (MRD) in Acute Myeloid Leukemia (AML). See the FNIH announcement here.
TwinStrand Biosciences - August 3, 2021
TwinStrand Biosciences Announces Filing of Patent Infringement Lawsuit Against Guardant Health
GenomeWeb - January 6, 2021
TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications
PRNewswire - November 18, 2020
TwinStrand Biosciences Licenses Duplex Sequencing Technology to Foundation Medicine
Puget Sound Business Journal - October 1, 2020
40 Under 40: Jesse Salk diagnoses cancer using DNA sequencing and treats the disease as a practicing oncologist
GEN - August 1, 2020
Liquid Biopsies Generate Ample Insights from Sparse Clues
Gene Online - July 20, 2020
The Profound Impact of Duplex Sequencing: An Interview with Jesse Salk, CEO, TwinStrand Biosciences
Bio-IT World - July 15, 2020
In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age
Timmerman Report - June 15, 2020
Timmerman Report- DNA Sequencing Startups Aim to Reduce Cost, Increase Meaning in the Data
GEN - April 1, 2020
Sequencing’s Stars Urge Exploration of New Dimensions
GEN - March 1, 2020
Genomic Medicine Identifies Reconcilable Differences
DeciBio - February 27, 2020
AGBT 2020: DeciBio Highlights – Spatial Profiling Reloaded & MGI Unleashed 2
PRNewswire - February 25, 2020
TwinStrand Biosciences Launches Duplex Sequencing Technology
LinkedIn - January 7, 2020
Leveraging big data to improve genome sequencing accuracy by 10,000x
